425 related articles for article (PubMed ID: 36222350)
1. From iron chelation to overload as a therapeutic strategy to induce ferroptosis in hematologic malignancies.
Li J; Zhang W
Hematology; 2022 Dec; 27(1):1163-1170. PubMed ID: 36222350
[TBL] [Abstract][Full Text] [Related]
2. Molecular Mechanisms of Ferroptosis and Its Roles in Hematologic Malignancies.
Zhao Y; Huang Z; Peng H
Front Oncol; 2021; 11():743006. PubMed ID: 34778060
[TBL] [Abstract][Full Text] [Related]
3. Ferroptosis in hematological malignancies and its potential network with abnormal tumor metabolism.
Zhang J; Liu Y; Li Q; Xu A; Hu Y; Sun C
Biomed Pharmacother; 2022 Apr; 148():112747. PubMed ID: 35240523
[TBL] [Abstract][Full Text] [Related]
4. Potential applications of ferroptosis inducers and regulatory molecules in hematological malignancy therapy.
Tang X; Niu Y; Jian J; Guo Y; Wang Y; Zhu Y; Liu B
Crit Rev Oncol Hematol; 2024 Jan; 193():104203. PubMed ID: 37979734
[TBL] [Abstract][Full Text] [Related]
5. Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage.
Wan J; Ren H; Wang J
Stroke Vasc Neurol; 2019 Jul; 4(2):93-95. PubMed ID: 31338218
[TBL] [Abstract][Full Text] [Related]
6. Mini-Review: Is iron-mediated cell death (ferroptosis) an identical factor contributing to the pathogenesis of some neurodegenerative diseases?
Viktorinova A; Durfinova M
Neurosci Lett; 2021 Feb; 745():135627. PubMed ID: 33440237
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis: Redox Imbalance and Hematological Tumorigenesis.
Lan H; Gao Y; Zhao Z; Mei Z; Wang F
Front Oncol; 2022; 12():834681. PubMed ID: 35155264
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis in Haematological Malignancies and Associated Therapeutic Nanotechnologies.
Mynott RL; Habib A; Best OG; Wallington-Gates CT
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108836
[TBL] [Abstract][Full Text] [Related]
9. Canonical Wnt signaling works downstream of iron overload to prevent ferroptosis from damaging osteoblast differentiation.
Luo C; Xu W; Tang X; Liu X; Cheng Y; Wu Y; Xie Z; Wu X; He X; Wang Q; Xiao Y; Qiu X; Tang Z; Shao G; Tu X
Free Radic Biol Med; 2022 Aug; 188():337-350. PubMed ID: 35752374
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Targeting of Ferroptosis in Cancer Treatment.
Valashedi MR; Nikoo A; Najafi-Ghalehlou N; Tomita K; Kuwahara Y; Sato T; Roushandeh AM; Roudkenar MH
Curr Cancer Drug Targets; 2022; 22(2):108-125. PubMed ID: 34856903
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis: Emerging Role in Diseases and Potential Implication of Bioactive Compounds.
Patanè GT; Putaggio S; Tellone E; Barreca D; Ficarra S; Maffei C; Calderaro A; Laganà G
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139106
[TBL] [Abstract][Full Text] [Related]
12. Future Perspectives of Oxytosis/Ferroptosis Research in Neurodegeneration Diseases.
Viktorinova A
Cell Mol Neurobiol; 2023 Aug; 43(6):2761-2768. PubMed ID: 37093436
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis as an emerging target in inflammatory diseases.
Mao H; Zhao Y; Li H; Lei L
Prog Biophys Mol Biol; 2020 Sep; 155():20-28. PubMed ID: 32311424
[TBL] [Abstract][Full Text] [Related]
14. Ferroptosis: Role of lipid peroxidation, iron and ferritinophagy.
Latunde-Dada GO
Biochim Biophys Acta Gen Subj; 2017 Aug; 1861(8):1893-1900. PubMed ID: 28552631
[TBL] [Abstract][Full Text] [Related]
15. Iron-mediated oxidative cell death is a potential contributor to neuronal dysfunction induced by neonatal hemolytic hyperbilirubinemia.
Viktorinova A
Arch Biochem Biophys; 2018 Sep; 654():185-193. PubMed ID: 30059654
[TBL] [Abstract][Full Text] [Related]
16. Novel 3-hydroxypyridin-4(1H)-One derivatives as ferroptosis inhibitors with iron-chelating and reactive oxygen species scavenging activities and therapeutic effect in cisplatin-induced cytotoxicity.
Zhang C; Lu Y; Zhang J; Zang A; Ren J; Zheng Z; Fan M; Xie Y
Eur J Med Chem; 2024 Jan; 263():115945. PubMed ID: 37976709
[TBL] [Abstract][Full Text] [Related]
17. Haemin-induced cell death in human monocytic cells is consistent with ferroptosis.
Imoto S; Kono M; Suzuki T; Shibuya Y; Sawamura T; Mizokoshi Y; Sawada H; Ohbuchi A; Saigo K
Transfus Apher Sci; 2018 Aug; 57(4):524-531. PubMed ID: 29859670
[TBL] [Abstract][Full Text] [Related]
18. Ferroptosis at the crossroads of manganese-induced neurotoxicity: A retrospective study.
Liu Y; Lv S; He G; Wang C; Ou C
Toxicology; 2024 Feb; 502():153727. PubMed ID: 38216111
[TBL] [Abstract][Full Text] [Related]
19. Nature-Inspired Bioactive Compounds: A Promising Approach for Ferroptosis-Linked Human Diseases?
El Hajj S; Canabady-Rochelle L; Gaucher C
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985608
[TBL] [Abstract][Full Text] [Related]
20. From Iron Metabolism to Ferroptosis: Pathologic Changes in Coronary Heart Disease.
Fan X; Li A; Yan Z; Geng X; Lian L; Lv H; Gao D; Zhang J
Oxid Med Cell Longev; 2022; 2022():6291889. PubMed ID: 35993022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
